Novavax research chief Gregory Glenn told Reuters the company will start much larger late-stage clinical trials soon and could potentially glean enough data to obtain regulatory approvals as early as December.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
No thanks I will takes my chances with covid
WJGunning Distraction from miserable failure.
Nothing as reassuring as a rushed vaccine. Wonder how many people will die from it.